ciprofloxacin has been researched along with Meningitis in 24 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Meningitis: Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied the entry of ciprofloxacin into the cerebrospinal fluid (CSF) in 37 patients with various types of meningitis (bacterial meningitis 10 patients, viral 12 patients, tuberculous 7 patients)." | 7.68 | Entry of ciprofloxacin into cerebrospinal fluid during bacterial, viral and tuberculous meningitis. ( Barsić, B; Beus, I; Himbele, J; Lisić, M; Marton, E; Schönwald, S, 1991) |
| "The potential of ciprofloxacin for the therapy of Pseudomonas aeruginosa meningitis was evaluated in an animal model by determining the penetration of the drug into CSF, its concentration-dependent killing characteristics in vivo, and its relative efficacy compared with ceftazidime and tobramycin." | 7.67 | Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits. ( Chambers, HF; Hackbarth, CJ; Sande, MA; Shibl, AM; Stella, F, 1986) |
| "We evaluated the diffusion of ciprofloxacin into the cerebrospinal fluid (CSF) in 23 patients with bacterial meningitis or ventriculitis undergoing treatment with other antibiotics." | 7.67 | Penetration of ciprofloxacin into cerebrospinal fluid of patients with bacterial meningitis. ( Boutron, L; Clair, B; Decazes, JM; Regnier, B; Singlas, E; Wolff, M, 1987) |
| "Underlying clinical syndromes were viral meningitis (n = 10), convalescent phase of acute bacterial meningitis (n = 9), and acute phase of bacterial meningitis (n = 1)." | 5.28 | Penetration of ciprofloxacin into the spinal fluid in patients with viral and bacterial meningitis. ( Borner, K; Ruhnke, M; Trautmann, M, 1990) |
| "Ciprofloxacin has been studied extensively in discriminative animal models of infection, and its efficacy in the treatment of these infections has been compared with that of standard therapy." | 5.27 | Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia. ( Brooks-Fournier, RA; Gerberding, JL; Sande, MA, 1987) |
| "We studied the entry of ciprofloxacin into the cerebrospinal fluid (CSF) in 37 patients with various types of meningitis (bacterial meningitis 10 patients, viral 12 patients, tuberculous 7 patients)." | 3.68 | Entry of ciprofloxacin into cerebrospinal fluid during bacterial, viral and tuberculous meningitis. ( Barsić, B; Beus, I; Himbele, J; Lisić, M; Marton, E; Schönwald, S, 1991) |
| "The potential of ciprofloxacin for the therapy of Pseudomonas aeruginosa meningitis was evaluated in an animal model by determining the penetration of the drug into CSF, its concentration-dependent killing characteristics in vivo, and its relative efficacy compared with ceftazidime and tobramycin." | 3.67 | Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits. ( Chambers, HF; Hackbarth, CJ; Sande, MA; Shibl, AM; Stella, F, 1986) |
| "We evaluated the diffusion of ciprofloxacin into the cerebrospinal fluid (CSF) in 23 patients with bacterial meningitis or ventriculitis undergoing treatment with other antibiotics." | 3.67 | Penetration of ciprofloxacin into cerebrospinal fluid of patients with bacterial meningitis. ( Boutron, L; Clair, B; Decazes, JM; Regnier, B; Singlas, E; Wolff, M, 1987) |
| "Tularemia is a zoonotic disease caused by Francisella tularensis." | 2.45 | Tularemic meningitis in the United States. ( Cardona, L; Davis, LE; Hofinger, DM; Mertz, GJ, 2009) |
| "Escherichia coli meningitis is a frequent pathology in children younger than 3 years old, but is an uncommon disease in adults." | 1.33 | E. coli multiresistant meningitis after transrectal prostate biopsy. ( Alecsandru, D; Garcia, A; Gestoso, I; Lobo, J; Martinez, A; Romero, A; Yagüe, MR, 2006) |
| "Fleroxacin was inactive against S." | 1.28 | In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin. ( Beskid, G; Chan, K; Cleeland, R; Keith, DD; McGarry, CM; Siebelist, J, 1990) |
| "Underlying clinical syndromes were viral meningitis (n = 10), convalescent phase of acute bacterial meningitis (n = 9), and acute phase of bacterial meningitis (n = 1)." | 1.28 | Penetration of ciprofloxacin into the spinal fluid in patients with viral and bacterial meningitis. ( Borner, K; Ruhnke, M; Trautmann, M, 1990) |
| "Ciprofloxacin has been studied extensively in discriminative animal models of infection, and its efficacy in the treatment of these infections has been compared with that of standard therapy." | 1.27 | Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia. ( Brooks-Fournier, RA; Gerberding, JL; Sande, MA, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (25.00) | 18.7374 |
| 1990's | 7 (29.17) | 18.2507 |
| 2000's | 9 (37.50) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Mäki-Koivisto, V | 1 |
| Korkala, M | 1 |
| Simola, L | 1 |
| Suutari-Kontio, S | 1 |
| Koivunen, S | 1 |
| Puhto, T | 1 |
| Junttila, IS | 1 |
| Parlak, E | 1 |
| Parlak, M | 1 |
| Atli, SB | 1 |
| Hofinger, DM | 1 |
| Cardona, L | 1 |
| Mertz, GJ | 1 |
| Davis, LE | 1 |
| Meyer, MA | 1 |
| Skoczyńska, A | 1 |
| Kadłubowski, M | 1 |
| Empel, J | 1 |
| Hryniewicz, W | 1 |
| Toumi, A | 1 |
| Loussaief, C | 1 |
| Ben Yahia, S | 1 |
| Ben Romdhane, F | 1 |
| Khairallah, M | 1 |
| Chakroun, M | 1 |
| Bouzouaïa, N | 1 |
| Ishikawa, T | 1 |
| Takata, T | 1 |
| Tsuboi, Y | 1 |
| Fujiki, F | 1 |
| Takamatsu, Y | 1 |
| Tamura, K | 1 |
| Alecsandru, D | 1 |
| Gestoso, I | 1 |
| Romero, A | 1 |
| Martinez, A | 1 |
| Garcia, A | 1 |
| Lobo, J | 1 |
| Yagüe, MR | 1 |
| Rodríguez-Baño, J | 1 |
| Martí, S | 1 |
| Soto, S | 1 |
| Fernández-Cuenca, F | 1 |
| Cisneros, JM | 1 |
| Pachón, J | 1 |
| Pascual, A | 1 |
| Martínez-Martínez, L | 1 |
| McQueary, C | 1 |
| Actis, LA | 1 |
| Vila, J | 1 |
| Hakola, K | 1 |
| Savola, J | 1 |
| Burke, P | 1 |
| Burne, SR | 1 |
| Ghadage, DP | 1 |
| Bal, AM | 1 |
| Beskid, G | 2 |
| Albrecht, HA | 1 |
| Fallat, V | 1 |
| Keith, DD | 2 |
| Lipschitz, ER | 1 |
| McGarry, CM | 2 |
| McGarry, DH | 1 |
| Rossman, P | 1 |
| Siebelist, J | 2 |
| Barsić, B | 1 |
| Himbele, J | 1 |
| Beus, I | 2 |
| Schönwald, S | 2 |
| Marton, E | 1 |
| Lisić, M | 2 |
| Gogos, CA | 1 |
| Maraziotis, TG | 1 |
| Papadakis, N | 1 |
| Beermann, D | 1 |
| Siamplis, DK | 1 |
| Bassaris, HP | 1 |
| Ragunathan, PL | 1 |
| Potkins, DV | 1 |
| Watson, JG | 1 |
| Kearns, AM | 1 |
| Carroll, A | 1 |
| Cleeland, R | 1 |
| Chan, K | 1 |
| Trautmann, M | 1 |
| Ruhnke, M | 1 |
| Borner, K | 1 |
| Car, V | 1 |
| Gmajnicki, B | 1 |
| Asperilla, MO | 1 |
| Smego, RA | 1 |
| Millar, MR | 1 |
| Bransby-Zachary, MA | 1 |
| Tompkins, DS | 1 |
| Hawkey, PM | 1 |
| Myles Gibson, R | 1 |
| Hackbarth, CJ | 1 |
| Chambers, HF | 1 |
| Stella, F | 1 |
| Shibl, AM | 1 |
| Sande, MA | 2 |
| Brooks-Fournier, RA | 1 |
| Gerberding, JL | 1 |
| Wolff, M | 1 |
| Boutron, L | 1 |
| Singlas, E | 1 |
| Clair, B | 1 |
| Decazes, JM | 1 |
| Regnier, B | 1 |
2 reviews available for ciprofloxacin and Meningitis
| Article | Year |
|---|---|
Tularemic meningitis in the United States.
Topics: Administration, Oral; Adult; Chloramphenicol; Ciprofloxacin; Diagnosis, Differential; Drug Therapy, | 2009 |
Neurologic complications of anthrax: a review of the literature.
Topics: Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Central Nervous System Infections; Ciprofloxacin | 2003 |
22 other studies available for ciprofloxacin and Meningitis
| Article | Year |
|---|---|
Positive Francisella tularensis meningitis outcome despite delayed identification: a case report.
Topics: Ciprofloxacin; Female; Francisella tularensis; Humans; Meningitis; Polymerase Chain Reaction; Tulare | 2023 |
Unusual cause of fatal anthrax meningitis.
Topics: Anthrax; Anti-Bacterial Agents; Ciprofloxacin; Fatal Outcome; Female; Humans; Meningitis; Middle Age | 2015 |
Characteristics of Haemophilus influenzae type b responsible for meningitis in Poland from 1997 to 2004.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefotaxime; Ciprofloxacin | 2005 |
[Meningitis revealing Rickettsia typhi infection].
Topics: Anti-Infective Agents; Ciprofloxacin; Female; Humans; Meningitis; Middle Aged; Retina; Rickettsia In | 2007 |
[Legionnaires' disease asssociated with meningitis and cerebellar ataxia].
Topics: Anti-Infective Agents; Cerebellar Ataxia; Ciprofloxacin; Consciousness Disorders; Humans; Legionnair | 2006 |
E. coli multiresistant meningitis after transrectal prostate biopsy.
Topics: Acute Disease; Aged; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy; Ciprofloxaci | 2006 |
Biofilm formation in Acinetobacter baumannii: associated features and clinical implications.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; B | 2008 |
[Meningitis caused by Francisella Tularensis].
Topics: Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Follow-Up Studies; Francisella tularensis; | 1996 |
Allergy associated with ciprofloxacin.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Drug Hypersensitivity; Female; Humans; Hypersensitivity | 2000 |
Antibiotic susceptibility pattern of Salmonella worthington isolated from neonates--a retrospective study.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Chloramphenicol; Ciprofloxacin; | 2002 |
In vitro and in vivo activity of carbamate-linked dual-action antibacterial Ro 24-4383.
Topics: Animals; Anti-Infective Agents; Cefotaxime; Ciprofloxacin; Gram-Negative Bacteria; Gram-Positive Bac | 1991 |
Entry of ciprofloxacin into cerebrospinal fluid during bacterial, viral and tuberculous meningitis.
Topics: Adult; Bacterial Infections; Ciprofloxacin; Humans; Meningitis; Meningitis, Viral; Middle Aged; Tube | 1991 |
Penetration of ciprofloxacin into human cerebrospinal fluid in patients with inflamed and non-inflamed meninges.
Topics: Adolescent; Adult; Aged; Ciprofloxacin; Female; Humans; Infusions, Intravenous; Male; Meningitis; Mi | 1991 |
Neonatal meningitis due to Salmonella typhimurium treated with ciprofloxacin.
Topics: Ciprofloxacin; Humans; Infant, Newborn; Meningitis; Salmonella Infections; Salmonella typhimurium | 1990 |
In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Cefotaxime; Ciprofloxacin; Drug Evaluation, Pr | 1990 |
Penetration of ciprofloxacin into the spinal fluid in patients with viral and bacterial meningitis.
Topics: Adult; Aged; Ciprofloxacin; Female; Humans; Male; Meningitis; Meningitis, Viral; Middle Aged; Tuberc | 1990 |
Ciprofloxacin in the treatment of gram-negative bacillary meningitis.
Topics: Adult; Aged; Bacterial Infections; Ciprofloxacin; Female; Gram-Negative Bacteria; Humans; Male; Meni | 1989 |
Eosinophilic meningitis associated with ciprofloxacin.
Topics: Adult; Ciprofloxacin; Eosinophilia; Female; Humans; Meningitis | 1989 |
Ciprofloxacin for Pseudomonas aeruginosa meningitis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Humans; Male; Meningitis; Middle Ag | 1986 |
Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits.
Topics: Animals; Ceftazidime; Ciprofloxacin; Disease Models, Animal; Meningitis; Pseudomonas aeruginosa; Pse | 1986 |
Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia.
Topics: Animals; Ciprofloxacin; Disease Models, Animal; Drug Evaluation, Preclinical; Endocarditis, Bacteria | 1987 |
Penetration of ciprofloxacin into cerebrospinal fluid of patients with bacterial meningitis.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Ciprofloxacin; Female; Humans; Kinetics; Male; Me | 1987 |